CSIRO Innovation Fund

Create to address the 'valley of death' between research and commercialisation.

The CSIRO Innovation Fund, managed by Main Sequence, has invested in 39 companies since it was formed in 2017. These companies have created over 1,200 jobs by working with partners in industry, CSIRO, and 22 Australian universities. Main Sequence’s origins within CSIRO reflect its commitment to amplifying connections between industry, research and infrastructure to accelerate deep technology development, and reinvesting economic returns from commercialisation back into science. Companies created with CSIRO include Coviu telehealth platform, Emesent drone technology, RapidAim biosecurity solution, v2food alternative protein, and Nourish Ingredients. You can read more about Main Sequence’s portfolio of investments and the global challenges they’re solving here

Relationships Interlocks Giving Data

Owners

CSIRO (Commonwealth Scientific and Industrial Research Organisation) National Science Research Laboratory of Australia

• Owner ('17→?); percent stake: 100%

Services & Transactions

Main Sequence Ventures Created by CSIRO | Invests in companies, cutting edge scientific discoveries with the world's biggest challenges to build nxt gen global companies.

• Service/Transaction ('17→?)

Updated over 2 years ago

Types	Organization, Business, Government-Sponsored Enterprise, Government Advisory Body
Region	Australia and Oceania

australia

CSIRO Innovation Fund

Create to address the 'valley of death' between research and commercialisation.

Owners

Services & Transactions

Basic Info

Tags

Source Links